Global Diabetes Devices Market Size By Product, By Distribution Channels, By End-Use Outlook, By Geographic Scope And Forecast
Report Highlights
Diabetes Devices Market Insights
Diabetes Devices Market was valued at USD 25.92 Billion in 2019 and is projected to reach USD 39.66 Billion by 2027, growing at a CAGR of 7% from 2020 to 2027.
The Diabetes Devices Market report provides a holistic evaluation of the market for the forecast period. The report comprises various segments as well as an analysis of the trends and factors that are playing a substantial role in the market. These factors; the market dynamics involve the drivers, restraints, opportunities, and challenges through which the impact of these factors in the market are outlined. The drivers and restraints are intrinsic factors whereas opportunities and challenges are extrinsic factors of the market. The Diabetes Devices Market study provides an outlook on the development of the market in terms of revenue throughout the prognosis period.
Global Diabetes Devices Market Overview
One of the major factors driving the global Diabetes Devices Market is the introduction of novel products in diabetes monitoring systems and treatment devices. Tandem Diabetes Care, Inc., for example, received FDA approval in February 2019 to market the first insulin pump with interoperable technology for children and adults with diabetes. The slim X2 insulin pump is the first device to go through a new de novo premarket review pathway. In January 2019, Bigfoot Biomedical announced a collaboration with Eli Lilly and Company to develop artificial intelligence-based solutions for optimizing insulin delivery and dosing.
This report provides an all-inclusive environment for the analysis of the Diabetes Devices Market. The market estimates provided in the report are the result of in-depth secondary research, primary interviews, and in-house expert reviews. These market estimates have been considered by studying the impact of various social, political, and economic factors along with the current market dynamics affecting the Diabetes Devices Market growth.
Along with the market overview, which comprises the market dynamics the chapter includes Porter’s Five Forces analysis which explains the five forces: namely buyers’ bargaining power, suppliers’ bargaining power, the threat of new entrants, the threat of substitutes, and degree of competition in the Diabetes Devices Market. It explains the various participants, such as system integrators, intermediaries, and end-users within the ecosystem of the market. The report also focuses on the competitive landscape of the Diabetes Devices Market.
Report Synopsis
| Report Metrics | Details |
| Base year considered | 2019 |
| Forecast period considered | 2020-2027 |
| Base year market size | 25.92 $ Billion |
| Market size forecast | 39.66 $ Billion |
| Growth rate | 7.0% |
| Units considered | $ Billion |
| Segments covered | Product, Distribution Channels, End-Use Outlook, and Geography. |
| Industry covered | Medical Device |
| Companies studied |
|
Global Diabetes Devices Market Segmentation Analysis
The Global Diabetes Devices Market is segmented on the basis of Product, Distribution Channels, End-Use Outlook, and Geography.
Key Players In Diabetes Devices Market
The Global Diabetes Devices Market study report will provide a valuable insight with an emphasis on the global market including some of the major players such as Roche Diagnostics Ltd, Johnson and Johnson, Bayer AG, Abbott Laboratories, Acon Laboratories, Medtronic plc, Terumo Corporation, Dexcom, Novo Nordisk A/S, Ypsomed AG.
Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.